Close Menu

NEW YORK (GenomeWeb) – Hologic said today that the US Food and Drug Administration has given it 510(k) clearance to market the Aptima Herpes Simplex Virus 1 & 2 molecular assay on its fully automated Panther system.

The assay, a nucleic acid amplification test used in conjunction with swab specimens from anogenital skin lesions, can be used to qualitatively detect and differentiate between HSV-1 and HSV-2. Clinicians collect samples using a new Aptima Multitest Swab Specimen Collection Kit or commercially available viral transport media.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The chief executive of the National Health Service in England is to call for tumor-agnostic drugs to be "fast-tracked," according to the Times.

Researchers in Australia are sequencing the Wollemi pine tree to try to protect it from extinction, Australia's ABC News reports.

Computerworld ranks Illumina as one of the top midsize organizations to work at in IT.

In Genome Research this week: links between biological aging and mutations affecting epigenetic regulators; long-read sequencing-based strategy to map chromatin accessibility; and more.